Search results for Lumretuzumab Biosimilar – Anti-ERBB3 mAb – Research Grade

Showing 1 – 10 of1products

ID: BAB868086551

Lumretuzumab Biosimilar – Anti-ERBB3 mAb – Research Grade, ProteoGenix, PX-TA1357

Description of Lumretuzumab Biosimilar - Anti-ERBB3 mAb - Research Grade General information on Anti-ERBB3[Homo sapiens] (Lumretuzumab) Monoclonal Antibody Lumretuzumab has been investigated for the treatment of Neoplasms, Breast Cancer, Non-Small Cell Lung Cancer.

Host

Reactivity

Applications

Conjugation

Compare

Request a product

Please provide the required information below so that we can quickly source your products.

Search results for Lumretuzumab Biosimilar – Anti-ERBB3 mAb – Research Grade

Suppliers